An investigation of the impact of the location and timing of antigen-specific T cell division on airways inflammation
S. Hutchison
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorB. S. W. Choo-Kang
Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, and
Search for more papers by this authorV. B. Gibson
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorR. V. Bundick
Discovery BioScience, AstraZeneca R&D Charnwood, Loughborough, UK
Search for more papers by this authorA. J. Leishman
Discovery BioScience, AstraZeneca R&D Charnwood, Loughborough, UK
Search for more papers by this authorJ. M. Brewer
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorI. B. McInnes
Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, and
Search for more papers by this authorP. Garside
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorS. Hutchison
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorB. S. W. Choo-Kang
Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, and
Search for more papers by this authorV. B. Gibson
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorR. V. Bundick
Discovery BioScience, AstraZeneca R&D Charnwood, Loughborough, UK
Search for more papers by this authorA. J. Leishman
Discovery BioScience, AstraZeneca R&D Charnwood, Loughborough, UK
Search for more papers by this authorJ. M. Brewer
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorI. B. McInnes
Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow, and
Search for more papers by this authorP. Garside
Centre for Biophotonics, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde,
Search for more papers by this authorSummary
It is widely accepted that allergic asthma is orchestrated by T helper type 2 lymphocytes specific for inhaled allergen. However, it remains unclear where and when T cell activation and division occurs after allergen challenge, and whether these factors have a significant impact on airways inflammation. We therefore employed a CD4-T cell receptor transgenic adoptive transfer model in conjunction with laser scanning cytometry to characterize the location and timing of T cell division in asthma in vivo. Thus, for the first time we have directly assessed the division of antigen-specific T cells in situ. We found that accumulation of divided antigen-specific T cells in the lungs appeared to occur in two waves. The first very early wave was apparent before dividing T cells could be detected in the lymph node (LN) and coincided with neutrophil influx. The second wave of divided T cells accumulating in lung followed the appearance of these cells in LN and coincided with peak eosinophilia. Furthermore, accumulation of antigen-specific T cells in the draining LN and lung tissue, together with accompanying pathology, was reduced by intervention with the sphingosine 1-phosphate receptor agonist FTY720 2 days after challenge. These findings provide greater insight into the timing and location of antigen-specific T cell division in airways inflammation, indicate that distinct phases and locations of antigen presentation may be associated with different aspects of pathology and that therapeutics targeted against leukocyte migration may be useful in these conditions.
References
- 1 Krug N, Frew AJ. The Th2 cell in asthma: initial expectations yet to be realised. Clin Exp Allergy 1997; 27: 142–50.
- 2 Henney CS, Waldman RH. Cell-mediated immunity shown by lymphocytes from the respiratory tract. Science 1970; 169: 696–7.
- 3 Ahlstedt S, Smedegard G, Nygren H, Bjorksten B. Immune responses in rats sensitized with aerosolized antigen. Antibody formation, lymphoblastic responses and mast cell and mucous cell development related to bronchial reactivity. Int Arch Allergy Appl Immunol 1983; 72: 71–8.
- 4 Xia W, Pinto CE, Kradin RL. The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med 1995; 181: 1275–83.
- 5 Bradley LM, Watson SR. Lymphocyte migration into tissue: the paradigm derived from CD4 subsets. Curr Opin Immunol 1996; 8: 312–20.
- 6 Mackay CR. Homing of naive, memory and effector lymphocytes. Curr Opin Immunol 1993; 5: 423–7.
- 7 Davenport MP, Grimm MC, Lloyd AR. A homing selection hypothesis for T-cell trafficking. Immunol Today 2000; 21: 315–7.
- 8 Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301–14.
- 9 Nakajima H, Iwamoto I, Tomoe S et al. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146: 374–7.
- 10 Gavett SH, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994; 10: 587–93.
- 11 Foster PS, Yang M, Herbert C, Kumar RK. CD4(+) T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma. Lab Invest 2002; 82: 455–62.
- 12 Krinzman SJ, De Sanctis GT, Cernadas M et al. T cell activation in a murine model of asthma. Am J Physiol 1996; 271: L476–83.
- 13 Lara-Marquez ML, Deykin A, Krinzman S et al. Analysis of T-cell activation after bronchial allergen challenge in patients with atopic asthma. J Allergy Clin Immunol 1998; 101: 699–708.
- 14 Walker C, Kaegi MK, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991; 88: 935–42.
- 15 Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J Exp Med 1991; 173: 1345–56.
- 16 Gong JL, McCarthy KM, Telford J, Tamatani T, Miyasaka M, Schneeberger EE. Intraepithelial airway dendritic cells: a distinct subset of pulmonary dendritic cells obtained by microdissection. J Exp Med 1992; 175: 797–807.
- 17 Holt PG, Schon-Hegrad MA, Oliver J. MHC class II antigen-bearing dendritic cells in pulmonary tissues of the rat. Regulation of antigen presentation activity by endogenous macrophage populations. J Exp Med 1988; 167: 262–74.
- 18 Holt PG, Schon-Hegrad MA, Oliver J, Holt BJ, McMenamin PG. A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium. Int Arch Allergy Appl Immunol 1990; 91: 155–9.
- 19 Idzko M, Hammad H, Van Nimwegen M et al. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J Clin Invest 2006; 116: 2935–44.
- 20 Idzko M, Hammad H, Van Nimwegen M et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007; 13: 913–9.
- 21 Connolly KM, Bogdanffy MS. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2′-deoxyuridine. J Histochem Cytochem 1993; 41: 1–6.
- 22 Murphy KM, Heimberger AB, Loh DY. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 1990; 250: 1720–3.
- 23 Hutchison S, Choo-Kang BSW, Bundick RV et al. Tumour necrosis factor alpha blockade suppresses murine allergic airways inflammation. Clinical & Experimental Immunology 2008; 151: 114–22.
- 24 Smith KM, McAskill F, Garside P. Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant, but they remain unable to provide B cell help. J Immunol 2002; 168: 4318–25.
- 25 Smith KM, Brewer JM, Rush CM, Riley J, Garside P. In vivo generated Th1 cells can migrate to B cell follicles to support B cell responses. J Immunol 2004; 173: 1640–6.
- 26 Pozarowski P, Holden E, Darzynkiewicz Z. Laser scanning cytometry: principles and applications. Methods Mol Biol 2006; 319: 165–92.
- 27 Grierson AM, Mitchell P, Adams CL et al. Direct quantitation of T cell signaling by laser scanning cytometry. J Immunol Methods 2005; 301: 140–53.
- 28 Lutz MB, Kukutsch N, Ogilvie AL et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223: 77–92.
- 29 Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994; 171: 131–7.
- 30 Ghazvini S, Kroll S, Char DH, Frigillana H. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma. Invest Ophthalmol Vis Sci 1995; 36: 2762–7.
- 31 Van Rijt LS, Vos N, Willart M et al. Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of Th2 effector responses in a mouse model of asthma. J Allergy Clin Immunol 2004; 114: 166–73.
- 32 Benvenuti F, Hugues S, Walmsley M et al. Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming. Science 2004; 305: 1150–3.
- 33 Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001; 410: 101–5.
- 34 Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997; 186: 1737–47.
- 35 Mathew A, Medoff BD, Carafone AD, Luster AD. Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J Immunol 2002; 169: 651–5.
- 36 Xu B, Wagner N, Pham LN et al. Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways. J Exp Med 2003; 197: 1255–67.
- 37 Catron DM, Rusch LK, Hataye J, Itano AA, Jenkins MK. CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cells. J Exp Med 2006; 203: 1045–54.
- 38 Durham SR, Till SJ, Corrigan CJ. T lymphocytes in asthma: bronchial versus peripheral responses. J Allergy Clin Immunol 2000; 106: S221–6.
- 39 Kohlmeier JE, Woodland DL. Memory T cell recruitment to the lung airways. Curr Opin Immunol 2006; 18: 357–62.
- 40 Wells JW, Cowled CJ, Giorgini A, Kemeny DM, Noble A. Regulation of allergic airway inflammation by class I-restricted allergen presentation and CD8 T-cell infiltration. J Allergy Clin Immunol 2007; 119: 226–34.
- 41 Kallinich T, Schmidt S, Hamelmann E et al. Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients. Clin Exp Allergy 2005; 35: 26–33.
- 42 Anderson GP. The immunobiology of early asthma. Med J Aust 2002; 177: S47–9.
- 43 Wikstrom ME, Batanero E, Smith M et al. Influence of mucosal adjuvants on antigen passage and CD4+ T cell activation during the primary response to airborne allergen. J Immunol 2006; 177: 913–24.
- 44 Lawrence CW, Braciale TJ. Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J Immunol 2004; 173: 1209–18.
- 45 Roman E, Miller E, Harmsen A et al. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J Exp Med 2002; 196: 957–68.
- 46 Akbari O, Freeman GJ, Meyer EH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 1024–32.
- 47 Akbari O, Stock P, Meyer E et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003; 9: 582–8.
- 48 Hoyne GF, Tan K, Corsin-Jimenez M et al. Immunological tolerance to inhaled antigen. Am J Respir Crit Care Med 2000; 162: S169–74.
- 49 Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today 2000; 21: 110–13.
- 50 Unger WW, Hauet-Broere F, Jansen W, Van Berkel LA, Kraal G, Samsom JN. Early events in peripheral regulatory T cell induction via the nasal mucosa. J Immunol 2003; 171: 4592–603.
- 51 Taube C, Dakhama A, Gelfand EW. Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol 2004; 135: 173–86.
- 52 Harris NL, Holloway J, Fitzharris P et al. Tissue localization and frequency of antigen-specific effector CD4 T cells determines the development of allergic airway inflammation. Immunol Cell Biol 2005; 83: 490–7.
- 53 Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532–9.
- 54 Martinez FD. Role of viral infections in the inception of asthma and allergies during childhood: could they be protective? Thorax 1994; 49: 1189–91.
- 55 Venuprasad K, Chattopadhyay S, Saha B. CD28 signaling in neutrophil induces T-cell chemotactic factor(s) modulating T-cell response. Hum Immunol 2003; 64: 38–43.
- 56 Van Rijt LS, Lambrecht BN. Dendritic cells in asthma: a function beyond sensitization. Clin Exp Allergy 2005; 35: 1125–34.
- 57 Jahnsen FL, Moloney ED, Hogan T, Upham JW, Burke CM, Holt PG. Rapid dendritic cell recruitment to the bronchial mucosa of patients with atopic asthma in response to local allergen challenge. Thorax 2001; 56: 823–6.
- 58 Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA. Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 1998; 160: 4090–7.
- 59 Hogan RJ, Usherwood EJ, Zhong W et al. Active antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol 2001; 166: 1813–22.
- 60 Marshall DR, Turner SJ, Belz GT et al. Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci USA 2001; 98: 6313–8.
- 61 Hogan RJ, Zhong W, Usherwood EJ, Cookenham T, Roberts AD, Woodland DL. Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med 2001; 193: 981–6.
- 62 Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol 2004; 16: 702–8.
- 63 Chiba K, Yanagawa Y, Masubuchi Y et al. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998; 160: 5037–44.
- 64 Brinkmann V, Pinschewer D, Chiba K, Feng L. FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation. Trends Pharmacol Sci 2000; 21: 49–52.
- 65 Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998; 160: 5493–9.
- 66 Sawicka E, Zuany-Amorim C, Manlius C et al. Inhibition of Th1- and Th2-mediated airway inflammation by the sphingosine 1-phosphate receptor agonist FTY720. J Immunol 2003; 171: 6206–14.
- 67 Kurashima Y, Kunisawa J, Higuchi M et al. Sphingosine 1-phosphate-mediated trafficking of pathogenic th2 and mast cells for the control of food allergy. J Immunol 2007; 179: 1577–85.
- 68 Daniel C, Sartory NA, Zahn N et al. FTY720 ameliorates oxazolone colitis in mice by directly affecting T helper type 2 functions. Mol Immunol 2007; 44: 3305–16.
- 69 Habicht A, Clarkson MR, Yang J et al. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection. J Immunol 2006; 176: 36–42.
- 70 Xie JH, Nomura N, Koprak SL, Quackenbush EJ, Forrest MJ, Rosen H. Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells. J Immunol 2003; 170: 3662–70.
- 71 Wang F, Tan W, Guo D, He S. Reduction of CD4 positive T cells and improvement of pathological changes of collagen-induced arthritis by FTY720. Eur J Pharmacol 2007; 573: 230–40.